Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Hezhong Chen is a leading surgical oncologist whose research centers on advancing minimally invasive techniques for esophageal cancer treatment, with a particular focus on esophageal squamous cell carcinoma (ESCC). His most impactful work compares robot-assisted minimally invasive esophagectomy (RAMIE) against conventional minimally invasive esophagectomy (MIE), demonstrating that robotic approaches can improve perioperative outcomes and long-term survival for patients with resectable ESCC. His landmark 2021 study, cited over 190 times, provides critical evidence supporting the adoption of robotic surgery in esophagectomy. Dr. Chen also designed and leads the multicenter prospective randomized controlled RAMIE trial, a pivotal study that establishes rigorous protocols for comparing surgical approaches. His contributions have helped define modern standards for esophageal cancer surgery, bridging the gap between technological innovation and clinical practice. With his work accumulating hundreds of citations, Dr. Chen is recognized as a key figure in the evolution of robotic-assisted thoracic surgery, influencing both surgical technique and patient care worldwide.